289507
Fmoc-OSu
96%
别名:
9-芴甲基 N-琥珀酰亚胺基碳酸酯, 9-芴甲基 N-琥珀酰亚氨基碳酸酯, N-(9-芴甲氧羰基氧基)琥珀酰亚胺, Fmoc-OSu
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C19H15NO5
化学文摘社编号:
分子量:
337.33
EC Number:
433-520-5
UNSPSC Code:
12352108
PubChem Substance ID:
Beilstein/REAXYS Number:
3569540
MDL number:
InChI key
WMSUFWLPZLCIHP-UHFFFAOYSA-N
InChI
1S/C19H15NO5/c21-17-9-10-18(22)20(17)25-19(23)24-11-16-14-7-3-1-5-12(14)13-6-2-4-8-15(13)16/h1-8,16H,9-11H2
SMILES string
O=C(OCC1c2ccccc2-c3ccccc13)ON4C(=O)CCC4=O
assay
96%
mp
150-153 °C (lit.)
application(s)
peptide synthesis
functional group
Fmoc
Application
选择性制备羟基-氨基酸 N-(9-芴甲氧羰基)衍生物的最有效试剂，反应具有高产率。比与氯甲酸酯、Fmoc-Cl 作用时的二肽形成率低。已用于合成糖肽。
Other Notes
This product has been replaced by 46920-ALDRICH | Fmoc N-hydroxysuccinimide ester ≥98.0% (HPLC)
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 2 - Skin Sens. 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Improved purities for Fmoc-amino acids from Fmoc-ONSu.
R C Milton et al.
International journal of peptide and protein research, 30(3), 431-432 (1987-09-01)
Occupational airborne allergic contact dermatitis from succinimidyl carbonates.
J F Fowler et al.
Contact dermatitis, 45(1), 38-38 (2001-06-26)
Huaimin Wang et al.
Scientific reports, 5, 16680-16680 (2015-11-18)
Biocompatible peptide-based supramolecular hydrogel has recently emerged as a new and promising system for biomedical applications. In this work, Rhodamine B is employed as a new capping group of self-assembling peptide, which not only provides the driving force for supramolecular
Ning Wang et al.
Carbohydrate research, 411, 37-41 (2015-05-15)
Monoglucosylated high-mannose-type glycan (Glc1Man9GlcNAc2: G1M9) is well-known as a key glycoform in the glycoprotein folding process, which is specifically recognized by lectin chaperones calnexin (CNX) and calreticulin (CRT) in the endoplasmic reticulum (ER). In this work, we developed an efficient
Arik Dahan et al.
Molecular pharmaceutics, 11(12), 4385-4394 (2014-11-05)
The efficacy of chemotherapeutic drugs is often offset by severe side effects attributable to poor selectivity and toxicity to normal cells. Recently, the enzyme dipeptidyl peptidase IV (DPPIV) was considered as a potential target for the delivery of chemotherapeutic drugs.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持